Acorda Therapeutics
ACOR
#8042
Rank
$16.4 M
Marketcap
$13.21
Share price
9.18%
Change (1 day)
2,177.76%
Change (1 year)

Operating Margin for Acorda Therapeutics (ACOR)

Operating Margin as of March 2024 (TTM): -84.50%

According to Acorda Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -84.50%. At the end of 2021 the company had an Operating Margin of -84.51%.

Operating Margin history for Acorda Therapeutics from 2011 to 2010

Operating Margin at the end of each year

Year Operating Margin Change
2021-84.51%20.06%
2020-70.39%-50.62%
2019-142.53%-3390.19%
20184.33%-110.12%
2017-42.82%426.35%
2016-8.13%-306.91%
20153.93%-43.65%
20146.98%-18.68%
20138.58%8.11%
20127.94%-27.57%
201110.96%-348.25%
2010-4.41%-97.03%
2009-148.62%-3.21%
2008-153.55%53.7%
2007-99.90%16.44%
2006-85.80%-87.17%
2005-668.73%-92.84%
2004-9,336.26%27.91%
2003-7,298.95%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-88.19% 4.37%๐Ÿ‡บ๐Ÿ‡ธ USA
27.34%-132.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-210.66% 149.30%๐Ÿ‡ฉ๐Ÿ‡ช Germany
4.83%-105.72%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.